Perampanel in lissencephaly-associated epilepsy

We retrospectively investigated whether perampanel (PER) could serve as an alternative for treating drug-resistant seizures in lissencephaly. We investigated the following data: age at onset of epilepsy, age at start of PER, etiology, brain MRI findings, seizure type, seizure frequency, adverse effe...

Descripción completa

Detalles Bibliográficos
Autores principales: Ikemoto, Satoru, Hamano, Shin-ichiro, Hirata, Yuko, Matsuura, Ryuki, Koichihara, Reiko
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Elsevier 2019
Materias:
Article
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6351285/
https://www.ncbi.nlm.nih.gov/pubmed/30723672
http://dx.doi.org/10.1016/j.ebcr.2019.01.001

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6351285/
https://www.ncbi.nlm.nih.gov/pubmed/30723672
http://dx.doi.org/10.1016/j.ebcr.2019.01.001

Ejemplares similares